Search results
Results From The WOW.Com Content Network
Pfizer is due to report its third-quarter earnings on Nov. 1. Julie Hyman is the co-anchor of Yahoo Finance Live, weekdays 9am-11am ET . Follow her on Twitter @juleshyman , and read her other stories.
COVID-19 gave a shot in the arm to Pfizer's sales and culture. Now CEO Albert Bourla lays out a plan to replace vaccine revenue as the virus' impact wanes.
Pfizer Inc. now foresees 2023 revenue in a range of $58 billion to $61 billion, down from its prior forecast for $67 billion to $70 billion. It now projects full-year adjusted earnings between $1. ...
In September 2023, the FDA approved an updated monovalent (single) component Omicron variant XBB.1.5 version of the vaccine (Comirnaty 2023–2024 formula) as a single dose for individuals aged twelve years of age and older; [30] and authorized the Pfizer-BioNTech COVID-19 Vaccine 2023–2024 formula under emergency use for individuals aged 6 ...
For premium support please call: 800-290-4726 more ways to reach us
Bourla was born and raised in Thessaloniki, Greece. [5] His parents, who were Sephardi Jews, were among the 2,000 of 50,000 Jews in Thessaloniki to survive the Holocaust; According to Bourla, his mother was allegedly minutes away from execution by firing squad when she was spared via a ransom paid to a Nazi Party official by her non-Jewish brother-in-law, while his father happened to be out of ...
In case 1, when the US Food and Drug Administration (FDA) limits the use of Pfizer's new painkiller Bextra, Pfizer distributes the pill illegally outside of FDA regulations. In case 2, Jeanetta Standefor invests money for troubled homeowners, but really she is just using investor money to pay off older investors and pocketing the rest.
The drugmaker said it now expects 2023 revenue of between $58 billion and $61 billion, down from it prior forecast of $67 billion to $70 billion. It said the reduction was solely due to lowered ...